Also of interest is the recovery of the LRP5 gene, a low-density lipoprotein receptor-related protein that has been identified as potentially oncogenic (Li and Bu 2005) and part of the cancer-drug-targeted Wnt/beta-catenin signaling pathway (Luu et al. 2004). The gene discussed is CTNNB1; the disease is cancer.